Sexually Transmitted Infections: Updates From the 2021 CDC Guidelines
Gonorrhea: What It Is, Symptoms, Treatment And More
Just a moment...This request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Press and HoldPress and hold the button
If you believe this is an error, please contact our support team.
167.71.87.121 : 251b705e-6ac1-42b9-9ee0-34a22748
5 STIs With No Symptoms Men Should Know About - Rolling Out
Recent medical studies reveal that asymptomatic sexually transmitted infections (STIs) present a growing public health concern, particularly among men. While some infections cause noticeable symptoms, health care providers report that many STIs can remain undetected for years, potentially leading to severe complications and unwitting transmission to partners.
The hidden danger of asymptomatic infectionsMedical research indicates that symptom-free STIs pose significant risks to public health. These infections can silently damage reproductive organs, increase cancer risks, and facilitate the transmission of other infections, including HIV. Health care professionals emphasize that the absence of symptoms does not indicate the absence of health risks.
Recent epidemiological data shows that asymptomatic cases account for approximately 70% of certain STI infections in men, highlighting the importance of regular screening regardless of apparent symptoms.
Chlamydia: Leading silent infectionChlamydia remains the most frequently reported bacterial STI nationwide, according to the Centers for Disease Control and Prevention (CDC). Medical studies indicate that up to 90% of infected men show no symptoms during early stages.
Health impacts include:
Current medical guidelines recommend annual screening for sexually active men, with more frequent testing for those with multiple partners or other risk factors.
Gonorrhea: Rising concernHealth care providers report an alarming increase in asymptomatic gonorrhea cases. Clinical studies show that up to 40% of infected men experience no immediate symptoms, creating opportunities for silent transmission.
Research indicates several serious complications:
Medical experts emphasize the importance of regular screening, as early detection significantly improves treatment outcomes.
HPV: Widespread threatHuman papillomavirus represents the most common sexually transmitted infection globally. Clinical data reveals that most sexually active individuals contract at least one strain during their lifetime, often without knowledge of infection.
Current research highlights several critical factors:
Health care providers strongly recommend HPV vaccination for all eligible males through age 45, noting that prevention remains more effective than treatment.
Trichomoniasis: Overlooked riskDespite being highly treatable, trichomoniasis often goes undiagnosed in men. Medical studies indicate that over 70% of infected males remain asymptomatic, though they can still transmit the infection effectively.
Clinical observations show:
Health care professionals emphasize that regular screening can easily identify and treat this infection before complications develop.
HIV: Critical early detectionMedical research consistently shows that early HIV infection often presents no symptoms, yet this period sees high transmission rates. Current studies indicate that early detection and treatment significantly improve long-term health outcomes.
Clinical data demonstrates:
Health care providers recommend regular HIV testing as part of routine health screenings, particularly for individuals with risk factors.
Prevention strategiesMedical experts emphasize comprehensive prevention approaches:
Health care professionals stress that the asymptomatic nature of many STIs makes regular screening essential for men's health. Current medical guidelines recommend risk-based testing schedules and emphasize the importance of preventive measures.
Recent public health data indicates that increased screening efforts could significantly reduce transmission rates and improve overall population health outcomes. Medical experts continue to advocate for regular testing as a crucial component of men's health care routines.
This story was created using AI technology.
Five Reasons Gonorrhea Is Becoming More Difficult To Treat
The front page picture of The Star newspaper released into the market on Thursday, January 12, 2023 featured significantly on Kenyans' WhatsApp and social media statuses.
The newspaper's lead story was titled 'Super gonorrhea strikes Nairobians', with the report stating that the Kenya Medical Research Institute (KEMRI) was concerned about the increase in the number of gonorrhea cases that are becoming more difficult to treat among city dwellers.
Typical of Kenyans, they took to social media to warn their friends and followers that reckless sex was becoming costlier by the day.
Many captioned the front-page image with the Swahili words "soko ni chafu", to mean "more and more people have STIs out here", and, therefore, caution is needed when engaging in sexual intercourse, especially with new partners.
The World Health Organization (WHO) said in a recent report that in 2020, there were 82.4 million new gonorrhea infections among adolescents and adults aged 15 to 49 years worldwide, with most of the cases registered in Africa and the western Pacific regions.
Gonorrhea is the second most common bacterial sexually transmitted infection (STI) after chlamydia.
In 2020, the WHO said there were 129 million new chlamydia infections in the world, followed by gonorrhea at 82.4 million.
In total, there were 374 million new STIs registered that year, with trichomoniasis leading with 156 million cases. Syphilis new infections that year were 7.1 million globally.
The WHO says that more than one million STIs are acquired every day worldwide, the majority of which are asymptomatic.
Gonorrhea, one of the commonest STIs in Africa, is caused by the bacterium Neisseria gonorrhoeae.
It infects the mucous membranes of the reproductive tract, including the cervix, uterus, and fallopian tubes in women, and the urethra in women and men.
The bacterium can also infect the mucous membranes of the mouth, throat, eyes, and rectum.
Symptoms
The Centers for Disease Control and Prevention (CDC) says gonorrhea is transmitted through sexual contact with the penis, vagina, mouth, or anus of an infected partner.
Ejaculation does not have to occur for gonorrhea to be transmitted or acquired. Gonorrhea can also be spread perinatally from mother to baby during childbirth.
Stay informed. Subscribe to our newsletter
The signs of gonorrhea infection among men include a white, yellow, or green smelly urethral discharge that usually appears one to 14 days after infection, a burning pain when passing urine, testicular or scrotal pain.
Most women with gonorrhea are asymptomatic. Even when a woman has symptoms, they are often so mild and nonspecific that they are mistaken for a bladder or vaginal infection, the CDC says.
The initial symptoms in women include increased vaginal discharge, or vaginal bleeding between periods. Women with gonorrhea are at risk of developing serious complications from the infection, regardless of the presence or severity of symptoms, says the CDC.
Serious health problems
Untreated gonorrhea can cause serious and permanent health problems in both women and men.
In women, gonorrhea can spread into the uterus or fallopian tubes and cause pelvic inflammatory disease, which can lead to internal abscesses and chronic pelvic pain. PID can also damage the fallopian tubes enough to cause infertility or increase the risk of ectopic pregnancy.
In men, untreated gonorrhea may lead to infertility. It can also spread to the blood and cause arthritis, tenosynovitis, and/or dermatitis, which can be life-threatening, says the CDC.
Gonorrhea can be diagnosed by testing urine, urethral specimen for men, or endocervical or vaginal specimen for women. It can also be diagnosed using gonorrhea culture, which requires endocervical or urethral swab specimens.
'Super gonorrhea'
Gonorrhea treatment has been effective over the years, though of late, the disease has become more resistant to drugs.
Dr. Teodora Wi, the WHO Medical Officer specialising in STIs, says the drug-resistant gonorrhea is now famously known as super gonorrhea.
"When we say 'super gonorrhea' we mean 'gonorrhea superbug'. These are extensively drug-resistant gonorrhea with high-level resistance to the current recommended treatment for gonorrhea (ceftriaxone and azithromycin) including resistance to penicillin, sulphonamides, tetracycline, fluoroquinolones, macrolides," said Dr. Wi as quoted by the WHO official website.
Why gonorrhea is resisting treatment
According to Dr. Wi, there are five reasons for the increased drug-resistance in gonorrhea treatment.
The reasons are unrestricted access to antimicrobials (products that kill or slow the spread of microorganisms), inappropriate selection and overuse of antibiotics, poor quality antibiotics, inherent genetic mutations within the organism which have contributed to the development of a pattern of resistance, and extra-genital infections (infections in the anus, throat and eyes).
Compared to other STIs such as syphilis, gonorrhea has the highest level of drug-resistance, the WHO says.
"The first line treatment of Benzathine penicillin remains highly effective, there has been evidence of resistance to azithromycin," said Dr. Wi.
Dr. Wi further said gonorrhea is extremely cruel to the reproductive system if left untreated.
If left untreated, gonorrhea exposes one to a five-fold increase of HIV transmission, infertility, inflammation; leading to acute and chronic lower abdominal pain in women, ectopic pregnancy and maternal death, first trimester abortion; and severe neonatal eye infections that may lead to blindness, said Dr. Wi.
Adults with gonorrhea are treated with a combined dose of antibiotics. Due to emerging strains of drug-resistant gonorrhea, the CDC recommends that uncomplicated gonorrhea be treated with the antibiotic ceftriaxone - given as an injection - with oral azithromycin (Zithromax).
If you're allergic to ceftriaxone, you might be given oral gemifloxacin (Factive) or injectable gentamicin and oral azithromycin.
"Increasing resistance to the last-line treatment for gonorrhea, poses a big challenge because it limits the treatment choices available for gonorrhea infections. The development of resistance clearly outpaces the development of new antibiotics. There is an urgent need to develop new treatment options for gonorrhea," says WHO's Dr. Teodora Wi.
Using a condom or other barrier method when engaging in sex can help lower one's chances of transmitting or contracting gonorrhea.
These barrier methods, however, won't always completely eliminate the risk of infection, especially if they aren't used properly.
Comments
Post a Comment